Wang, E., Mathai, D. S., Gukasyan, N., Nayak, S., & Garcia-Romeu, A. (2024). Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-78736-1

How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety? (2024). AMA Journal of Ethics, 26(11), E868-874. https://doi.org/10.1001/amajethics.2024.868

Attia, E., & Steinglass, J. E. (2023). Psilocybin for anorexia nervosa: If it helps, let’s learn how. Med, 4(9), 581–582. https://doi.org/10.1016/j.medj.2023.08.003

Hasin, D. (2023). Legalization of cannabis for medical and recreational use. European Psychiatry, 66(S1), S20–S21. https://doi.org/10.1192/j.eurpsy.2023.83

Walsh, C. A., Livne, O., Shmulewitz, D., Stohl, M., & Hasin, D. S. (2022). Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002–2019. Addictive Behaviors Reports, 16, 100454. https://doi.org/10.1016/j.abrep.2022.100454